Andrew Fein
Stock Analyst at HC Wainwright & Co.
(2.15)
# 2,546
Out of 4,810 analysts
596
Total ratings
34.62%
Success rate
-5.99%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARVN Arvinas | Reiterates: Buy | $81 | $7.40 | +994.59% | 18 | Apr 7, 2025 | |
| IMAB I-Mab | Maintains: Buy | $8 → $7 | $0.96 | +632.45% | 13 | Apr 4, 2025 | |
| ACIU AC Immune | Reiterates: Buy | $16 | $1.52 | +952.63% | 15 | Apr 3, 2025 | |
| KROS Keros Therapeutics | Reiterates: Buy | $40 | $12.74 | +213.97% | 14 | Apr 1, 2025 | |
| PVLA Palvella Therapeutics | Reiterates: Buy | $38 | $24.44 | +55.48% | 5 | Apr 1, 2025 | |
| ABOS Acumen Pharmaceuticals | Maintains: Buy | $15 → $11 | $1.10 | +900.00% | 11 | Mar 28, 2025 | |
| SVRA Savara | Reiterates: Buy | $6 | $2.90 | +106.90% | 12 | Mar 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $1.22 | +719.67% | 18 | Mar 27, 2025 | |
| WVE Wave Life Sciences | Reiterates: Buy | $22 | $6.00 | +266.67% | 12 | Mar 26, 2025 | |
| LQDA Liquidia | Reiterates: Buy | $29 | $13.83 | +109.69% | 12 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $7.56 | +521.69% | 13 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $26.91 | +167.56% | 4 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $7.47 | +515.80% | 11 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.60 | +235.06% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $1.60 | +775.00% | 13 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $11.95 | +67.36% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.18 | +916.95% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $3.59 | +262.12% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.28 | +75.16% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $4.14 | +455.56% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.24 | +1,109.68% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.89 | +176.82% | 1 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $3.90 | +207.69% | 19 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $42.43 | +100.33% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $22.80 | +53.51% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $60 | $25.43 | +135.94% | 7 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $87 | $13.27 | +555.61% | 21 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $14.86 | +81.70% | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $425 | $284.31 | +49.48% | 14 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.98 | +613.70% | 9 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $2.92 | +36.99% | 17 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.04 | +326.14% | 9 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.10 | +1,354.55% | 11 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $9.94 | +382.90% | 16 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $185 | $94.89 | +94.96% | 19 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $71.03 | +26.71% | 13 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $5.80 | +1,193.10% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $135 | $82.53 | +63.58% | 17 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $241 | $119.26 | +102.08% | 19 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $550 | $495.83 | +10.93% | 26 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $20.06 | +273.88% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $18.95 | +322.16% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.53 | +1,860.78% | 14 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $35 | $7.79 | +349.29% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.97 | +724.74% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $1.23 | +469.11% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.39 | +85.53% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $1.91 | +1,994.24% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.56 | +26,552.45% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $3 | $9.47 | -68.32% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $2.12 | +607.55% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.58 | +2,431.65% | 3 | Mar 16, 2022 |
Arvinas
Apr 7, 2025
Reiterates: Buy
Price Target: $81
Current: $7.40
Upside: +994.59%
I-Mab
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $0.96
Upside: +632.45%
AC Immune
Apr 3, 2025
Reiterates: Buy
Price Target: $16
Current: $1.52
Upside: +952.63%
Keros Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $12.74
Upside: +213.97%
Palvella Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $38
Current: $24.44
Upside: +55.48%
Acumen Pharmaceuticals
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.10
Upside: +900.00%
Savara
Mar 28, 2025
Reiterates: Buy
Price Target: $6
Current: $2.90
Upside: +106.90%
Zentalis Pharmaceuticals
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.22
Upside: +719.67%
Wave Life Sciences
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $6.00
Upside: +266.67%
Liquidia
Mar 20, 2025
Reiterates: Buy
Price Target: $29
Current: $13.83
Upside: +109.69%
Mar 19, 2025
Reiterates: Buy
Price Target: $47
Current: $7.56
Upside: +521.69%
Mar 18, 2025
Reiterates: Buy
Price Target: $72
Current: $26.91
Upside: +167.56%
Mar 17, 2025
Reiterates: Buy
Price Target: $46
Current: $7.47
Upside: +515.80%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.60
Upside: +235.06%
Mar 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.60
Upside: +775.00%
Mar 14, 2025
Reiterates: Buy
Price Target: $20
Current: $11.95
Upside: +67.36%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.18
Upside: +916.95%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $3.59
Upside: +262.12%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $6.28
Upside: +75.16%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $4.14
Upside: +455.56%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.24
Upside: +1,109.68%
Mar 6, 2025
Initiates: Buy
Price Target: $8
Current: $2.89
Upside: +176.82%
Mar 5, 2025
Reiterates: Buy
Price Target: $12
Current: $3.90
Upside: +207.69%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $42.43
Upside: +100.33%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $22.80
Upside: +53.51%
Feb 28, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $25.43
Upside: +135.94%
Feb 28, 2025
Maintains: Buy
Price Target: $80 → $87
Current: $13.27
Upside: +555.61%
Feb 27, 2025
Reiterates: Buy
Price Target: $27
Current: $14.86
Upside: +81.70%
Feb 27, 2025
Reiterates: Buy
Price Target: $425
Current: $284.31
Upside: +49.48%
Feb 27, 2025
Reiterates: Buy
Price Target: $7
Current: $0.98
Upside: +613.70%
Feb 26, 2025
Reiterates: Neutral
Price Target: $4
Current: $2.92
Upside: +36.99%
Feb 25, 2025
Reiterates: Buy
Price Target: $30
Current: $7.04
Upside: +326.14%
Feb 24, 2025
Reiterates: Buy
Price Target: $16
Current: $1.10
Upside: +1,354.55%
Feb 24, 2025
Reiterates: Buy
Price Target: $48
Current: $9.94
Upside: +382.90%
Feb 24, 2025
Reiterates: Buy
Price Target: $185
Current: $94.89
Upside: +94.96%
Feb 24, 2025
Reiterates: Buy
Price Target: $90
Current: $71.03
Upside: +26.71%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $5.80
Upside: +1,193.10%
Feb 14, 2025
Reiterates: Buy
Price Target: $135
Current: $82.53
Upside: +63.58%
Feb 13, 2025
Maintains: Buy
Price Target: $300 → $241
Current: $119.26
Upside: +102.08%
Feb 11, 2025
Reiterates: Buy
Price Target: $550
Current: $495.83
Upside: +10.93%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $20.06
Upside: +273.88%
Dec 20, 2024
Reiterates: Buy
Price Target: $80
Current: $18.95
Upside: +322.16%
Dec 17, 2024
Reiterates: Buy
Price Target: $30
Current: $1.53
Upside: +1,860.78%
Oct 24, 2024
Maintains: Buy
Price Target: $25 → $35
Current: $7.79
Upside: +349.29%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $0.97
Upside: +724.74%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $1.23
Upside: +469.11%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $5.39
Upside: +85.53%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $1.91
Upside: +1,994.24%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.56
Upside: +26,552.45%
May 5, 2022
Downgrades: Neutral
Price Target: $10 → $3
Current: $9.47
Upside: -68.32%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $2.12
Upside: +607.55%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.58
Upside: +2,431.65%